Clinical trials
Hyperlipidemias trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Riphah International University | 4 |
| University of Lahore | 3 |
| University of Veterinary and Animal Sciences, Lahore - Pakistan | 2 |
| Hamdard University | 1 |
| Jinnah Sindh Medical University | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Shaheed Zulfiqar Ali Bhutto Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 13 |
| Hypertension | 3 |
| Body Weight Changes | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Metabolic Syndrome | 2 |
| Obesity | 2 |
| Dyslipidemias | 1 |
| Hypercholesterolemia | 1 |
| Hyperglycemia | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.